Latest News and Updates | Cantargia

* (R) = Regulatory press releases

Mar 5, 2026

Cantargia to participate at Van Lanschot Kempen’s Life Sciences Conference

Feb 23, 2026

Cantargia to participate in TD Cowen’s Annual Healthcare Conference

Feb 20, 2026

(R) Cantargia publishes Full Year Report 2025

Feb 6, 2026

Invitation to the Presentation of Cantargia’s Annual Results for 2025

Jan 28, 2026

Cantargia to participate at Leerink Partners Global Healthcare Conference

Jan 23, 2026

Cantargia Reports First Patient Dosed in New US Investigator-Initiated Colorectal Cancer Study

Dec 5, 2025

(R) Cantargia Provides Update on Overall Survival Data from TRIFOUR

Nov 19, 2025

(R) Cantargia Publishes Interim Report for January to September 2025

Nov 12, 2025

(R) Cantargia presents Nomination Committee ahead of 2026 AGM

Nov 5, 2025

Invitation to the Presentation of Cantargia’s Interim Report January-September 2025

<< Newer press releases Older press releases >>

Interview with CEO Hilde H. Steineger - 2025-10-24

Redeye

Interview with CEO Hilde H. Steineger - 2025-10-07

BioStock

Interview with CSO David Liberg about new nadunolimab data in pancreatic cancer presented at AACR Pancreas Conference (In Swedish) - 2025-10-01

Redeye

Interview with Damian Marron about Otsuka Pharmaceutical's acquisition of CAN10 - 2025-07-17

BioStock

Interview with Damian Marron regarding the acquisition of CAN10 IL1RAP immunology program by Otsuka Pharmaceutical - 2025-07-15

Redeye

Cantargia Q1 2025 interview with Interim CEO Damian Marron - 2025-05-14

Redeye

Redeye interviews Interim CEO Damian Marron - 2025-02-07

Redeye